Gladstone Institutional Advisory’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-12,205
Closed -$432K 271
2020
Q2
$432K Buy
12,205
+1,417
+13% +$40.3K 0.11% 141
2020
Q1
$236K Buy
+10,788
New +$242K 0.06% 221

Other funds holding CDNA

Gladstone Institutional Advisory's CDNA Position: Q3 2020 in Review

Gladstone Institutional Advisory sold out of CareDx (CDNA) in Q3 2020, closing a stake of 12,205 shares — an estimated $432K sold.

Gladstone Institutional Advisory first reported a position in CDNA in Q1 2020 and held it in 2 quarters. The position peaked at $432K in Q2 2020. 197 funds tracked by Wall St. Rank hold CDNA as of Q3 2020.

  • Gladstone Institutional Advisory reported no remaining CareDx position as of Q3 2020 after selling out during the quarter.
  • Gladstone Institutional Advisory sold 12,205 CareDx shares in Q3 2020, an estimated $432K.
  • Gladstone Institutional Advisory first reported a position in CareDx in Q1 2020 and held it in 2 quarters.
  • Gladstone Institutional Advisory's CareDx position peaked at $432K in Q2 2020.
  • 197 funds tracked by Wall St. Rank held CareDx as of Q3 2020.

Based on Gladstone Institutional Advisory's 13F filing for Q3 2020, filed 16 Nov 2020.